Losartan Potassium
Product Images NDC 45865-687

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 45865-687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (687)

This text seems to be a partial label or prescription information for a medication named Losartan Potassium. The tablets contain 25mg and are manufactured by a company named "BHARN." The recommended daily dosage is five tablets or as directed by a healthcare professional. The text suggests that the medication may have interactions with calcium supplements, dizziness, and alcohol.*

FDA Label Image

Figure 1 (92296151 E507 41b4 A040 C01b87ecb982 01)

FDA Label Image

Figure 2 (92296151 E507 41b4 A040 C01b87ecb982 02)

The text provides information on a study involving Atenolol and Losartan Potassium Tablets. The study tracked the percentage of patients with the primary endpoint over 65 months, and shows an adjusted risk reduction of 13% with a p-value of 0.021.*

FDA Label Image

Figure 3 (92296151 E507 41b4 A040 C01b87ecb982 03)

The text seems to be a table comparing the effectiveness of Atenolol and Losartan Potassium Tablets in reducing the risk of fatal and non-fatal stroke in patients. The table shows the percentage of patients who suffered from strokes over a period of 68 months in both treatments. It also indicates that the adjusted risk reduction of Losartan Potassium Tablets was 25%, with a significance level of p = 0.001.*

FDA Label Image

Figure 4 (92296151 E507 41b4 A040 C01b87ecb982 04)

FDA Label Image

Figure 5 (92296151 E507 41b4 A040 C01b87ecb982 05)

This seems to be a table related to a clinical trial or study, which shows the percentage of patients who experienced an event in a certain condition, along with the estimated risk reduction percentage and a value of 0.022. The table also includes the name of a medication called "Losartan Potassium Tablets" and a "Placebo", suggesting that the study may have evaluated the effectiveness of this medication compared to a placebo.*

FDA Label Image

Figure 6 (92296151 E507 41b4 A040 C01b87ecb982 06)

FDA Label Image

Figure 6 (92296151 E507 41b4 A040 C01b87ecb982 07)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.